New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer

被引：0
|
作者：
Chuying Huo [1 ]
Bin Wu [2 ]
Dongdong Ye [1 ]
Miaochun Xu [1 ]
Shaolin Ma [3 ]
Aoshuang Cheng [1 ]
Yunyun Liu [2 ]
Chunxian Huang [1 ]
Yuhao Zhang [2 ]
Zhongqiu Lin [1 ]
Bowen Li [2 ]
Huaiwu Lu [1 ]
机构：
[1] Sun Yat-Sen University,Department of Gynecologic Oncology, Sun Yat
[2] Sun Yat-Sen University,Sen Memorial Hospital
[3] Huazhong University of Science and Technology,Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat
[4] Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,Sen Memorial Hospital
[5] Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases,Department of Gynecology and Obstetrics, Union Hospital, Tongji Medical College
来源：
BMC Cancer | / 24卷 / 1期
关键词：
High-grade serous ovarian cancer; Neoadjuvant chemotherapy; Prognostic index;
D O I：
10.1186/s12885-024-13324-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Chemotherapy response score after neoadjuvant chemotherapy in ovarian advanced high-grade serous carcinoma correlates with peritoneal cancer index
    Torralba, I.
    Martinez, M. A.
    Rodrigo, H.
    Quintero, A. M.
    Velasquez, J. R.
    Matheu, G.
    VIRCHOWS ARCHIV, 2018, 473 : S77 - S77
  • [2] Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer
    Lee, Sanghoon
    Zhao, Li
    Fleming, Nicole D.
    Celestino, Joseph
    Hajek, Richard A.
    Morgan, Margaret B.
    Liu, Yan
    Westin, Shannon N.
    Jazaeri, Amir A.
    Liu, Jinsong
    Zhang, Jianhua
    Futreal, P. Andrew
    Sood, Anil K.
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy
    Lee, J-Y.
    Paik, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy
    Lee, Yong J.
    Kim, Dachan
    Shim, Jung E.
    Bae, Su-Jin
    Jung, Yu-Jin
    Kim, Sora
    Lee, Hanna
    Kim, So H.
    Jo, Su B.
    Lee, Jung-Yun
    Kim, Hyun-Soo
    Paik, Soonmyung
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (07) : 1851 - 1861
  • [5] Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence for high-grade serous ovarian cancer patients with advanced disease
    Li, J.
    Wu, M-F.
    Li, H.
    Lin, Z-Q.
    Wang, L-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1336 - S1336
  • [6] Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy
    Watanabe, Masao
    Nakamoto, Yuji
    Ishimori, Takayoshi
    Saga, Tsuneo
    Kido, Aki
    Hamanishi, Junzo
    Hamanaka, Yasuyo
    Togashi, Kaori
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (02) : 128 - 135
  • [7] Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy
    Masao Watanabe
    Yuji Nakamoto
    Takayoshi Ishimori
    Tsuneo Saga
    Aki Kido
    Junzo Hamanishi
    Yasuyo Hamanaka
    Kaori Togashi
    Annals of Nuclear Medicine, 2020, 34 : 128 - 135
  • [8] Impact of neoadjuvant chemotherapy duration on the survival of patients with advanced stage high-grade serous or endometrioid ovarian carcinoma
    Nasioudis, Dimitrios
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Simpkins, Fiona
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S183 - S184
  • [9] Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
    Montgomery, A. M.
    Crossman, D. K.
    Yang, E. S.
    Alvarez, R. D.
    Huh, W. K.
    Bevis, K. S.
    Straughn, J. M., Jr.
    Leath, C. A., III
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 12 - 13
  • [10] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824
12345